Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2018-04-16 2017-11-06
Drug Identification Number 02246316 02246316
Brand name GABAPENTIN GABAPENTIN
Common or Proper name GABAPENTIN GABAPENTIN
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients GABAPENTIN GABAPENTIN
Strength(s) 400MG 400MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2017-06-15 2017-06-15
Estimated end date 2018-04-27 Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Temporarily unavailable Temporarily unavailable
Health Canada comments